Jodi Devlin's most recent trade in TriSalus Life Sciences Inc was a trade of 24,131 Common Stock done at an average price of $5.2 . Disclosure was reported to the exchange on May 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TriSalus Life Sciences Inc | Jodi Devlin | Chief of Clinical Operations | Grant, award, or other acquisition of securities at price $ 5.18 per share. | 19 May 2025 | 24,131 | 57,528 | - | 5.2 | 124,999 | Common Stock |
TriSalus Life Sciences Inc | Jodi Devlin | Chief of Clinical Operations | Sale of securities on an exchange or to another person at price $ 5.18 per share. | 19 May 2025 | 4,764 | 52,764 | - | 5.2 | 24,678 | Common Stock |
TriSalus Life Sciences Inc | Jodi Devlin | Chief of Clinical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 5,272 | 33,397 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Jodi Devlin | Chief of COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Jodi Devlin | Chief of COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,625 | 28,125 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Jodi Devlin | PRESIDENT, COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Jodi Devlin | PRESIDENT, COMMERC. OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 17,500 | 17,500 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Jodi Devlin | President, Therapeutics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2023 | 195,000 | 195,000 | - | - | Employee Stock Option (right to buy) |